Nicole Arndt | Senior Manager, IR |
Ryan Spencer | CEO & Director |
Donn Casale | SVP, Commercial |
Robert Janssen | Chief Medical Officer and SVP, Clinical Development, Medical & Regulatory Affairs |
Kelly MacDonald | SVP & CFO |
Ernie Rodriguez | Cowen and Company |
Matthew Phipps | William Blair & Company |
Robert Palermo | Goldman Sachs Group |
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies First Quarter 2022 Financial Results.
As a reminder, this conference call is being recorded. [Operator Instructions]. I would now like to turn the call over to Nicole Arndt, Senior Manager, Investor Relations.
You may begin.